<DOC>
	<DOCNO>NCT00802425</DOCNO>
	<brief_summary>The purpose study determine whether AM-111 effective treatment acute inner ear hearing loss ( acute sensorineural hearing loss , ASNHL ) .</brief_summary>
	<brief_title>Efficacy AM-111 Patients With Acute Sensorineural Hearing Loss</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Hearing Loss , Sensorineural</mesh_term>
	<criteria>Patients unilateral acute sensorineural hearing loss ( ASNHL ) onset 48 hour less ago Mean earing loss compare unaffected contralateral ear least 30 dB 3 affect contiguous frequency Age ≥ 18 year ≤ 60 year Negative pregnancy test woman childbearing potential Able attend onstudy visit Written inform consent participation study Bilateral ASNHL , result acoustic trauma Suspected perilymph fistula membrane rupture Barotrauma Average air bone gap high 20 dB 3 contiguous frequency History Meniere disease , autoimmune hearing loss , radiationinduced hearing loss , endolymphatic hydrops , suspect retrocochlear lesion fluctuate hearing loss Previous ASNHL incident within past 6 week Evidence acute chronic otitis medium otitis externa examination Any drugbased therapy inner ear hear loss ongoing perform past 2 week Any ongoing plan concomitant medication treatment tinnitus 30 day administration Any therapy know ototoxic ( e.g . aminoglycosides , cisplatin , loop diuretic , quinine etc . ) past 6 month prior study inclusion History drug abuse alcoholism Any clinically relevant respiratory , cardiovascular , neurological ( except vertigo tinnitus ) , psychiatric disorder Known hypersensitivity , allergy intolerance study medication history severe abnormal drug reaction Women breastfeeding , pregnant plan pregnancy trial Women childbearing potential declare unwilling unable practice contraception combine oral contraceptive , injectables , hormonal intrauterine device , vasectomise partner sexual abstinence Concurrent participation another clinical trial participation another clinical trial within 30 day prior study entry Any current anticoagulant therapy ( e.g . Aspirin , Marcumar , etc )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Sudden hearing loss</keyword>
	<keyword>Sudden deafness</keyword>
	<keyword>Acoustic trauma</keyword>
	<keyword>Noise trauma</keyword>
</DOC>